Press release
Advanced Renal Cell Carcinoma Treatment Market Size Projected To Reach 11.77 Billion By 2034 With A Cagr Of 7.7%
Advanced Renal Cell Carcinoma Treatment
What Is the Projected Growth of the Advanced Renal Cell Carcinoma Treatment Market?
The market size for treatment of advanced renal cell carcinoma has seen robust growth in the past years. Expected to rise from $8.10 billion in 2024, it will reach $8.75 billion in 2025, experiencing a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth in the historical period include the rising size of the elderly population, higher incidence of smoking, increase in hypertension cases, greater healthcare spending, and a surge in renal cancer cases.
In the forthcoming years, the market size for advanced renal cell carcinoma treatment is set to experience robust growth. By 2029, it's estimated to reach $11.77 billion, with a compound annual growth rate (CAGR) of 7.7%. This anticipated growth during the forecast period can be linked to factors such as a rise in genetic diseases, increased occurrences of chronic hypertension, utilization of tyrosine kinase inhibitors, amplified awareness about kidney cancer, and heightening investments in research and development. Key trends for the forecasted era encompass enhancements in diagnostic technology, progress in targeted treatments, the creation of oral therapies, advancements in liquid biopsy procedures, and the incorporation of artificial intelligence in the formulation of drugs.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21090
What Are the Different Advanced Renal Cell Carcinoma Treatment Market Segments?
The advanced renal cell carcinoma treatment market covered in this report is segmented -
1) By Treatment: Biologics, Radiation Therapy, Chemotherapy, Hormone, Vaccine Therapy, Other Treatments
2) By Route Of Administration: Parental, Oral, Other Route Of Administrations
3) By End User: Hospitals, Cancer Research Institutes, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Biologics: Monoclonal Antibodies, Immune Checkpoint Inhibitors, Cytokine Therapy, Targeted Small Molecule Inhibitors
2) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Stereotactic Body Radiation Therapy (SBRT), Proton Beam Therapy
3) By Chemotherapy: Platinum-Based Chemotherapy, Antimetabolites, Alkylating Agents
4) By Hormone Therapy: Androgen Deprivation Therapy (ADT), Estrogen Receptor Modulators
5) By Vaccine Therapy: Peptide-Based Cancer Vaccines, Dendritic Cell Vaccines, DNA-Based Cancer Vaccines
6) By Other Treatments: Cryoablation, Radiofrequency Ablation (RFA), Combination Therapy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21090&type=smp
What Are the Primary Drivers Shaping the Advanced Renal Cell Carcinoma Treatment Market?
The escalating incidence of genetic disorders is believed to drive the expansion of the advanced renal cell carcinoma (RCC) treatment market. Genetic disorders are illnesses or conditions resulting from DNA irregularities in a person, which could either be inherited from one or both parents or stem from mutations during an individual's lifetime. The rise in such conditions can be traced back to developments in diagnostic technology, heightened awareness and reporting, as well as lifestyle shifts and environmental forces interacting with genetic predispositions. With the help of advanced RCC treatment, genetic disorders can be managed by targeting certain molecular pathways, thereby paving the way for tailored therapies addressing the genetic root of tumor growth and progression. For example, in June 2023, Gene People, a registered charity in the UK, projected that genetic disorders affect 1 out of 25 children, with more than 2.4 million individuals in the UK living with such a condition. Apart from this, almost 30,000 newborns and children in the UK are diagnosed with a genetic disorder yearly. Hence, it's evident that the rising incidence of genetic disorders is stimulating the growth of the advanced renal cell carcinoma (RCC) treatment market.
Which Companies Are Leading in the Advanced Renal Cell Carcinoma Treatment Market?
Major companies operating in the advanced renal cell carcinoma treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Ipsen SA, Exelixis Inc., BeiGene Ltd., Bavarian Nordic A/S, Telix Pharmaceuticals Limited, CRISPR Therapeutics AG, Beijing Scitech-Mq Pharmaceuticals Limited, HUTCHMED (China) Limited, Arcus Biosciences Inc., NGM Biopharmaceuticals Inc., Mirati Therapeutics Inc.
What Are the Major Trends Shaping the Advanced Renal Cell Carcinoma Treatment Market?
In the advanced renal cell carcinoma (RCC) treatment market, prominent companies are directing their efforts towards the creation of novel products such as hypoxia-inducible factor-2 alpha (HIF-2α) inhibitors. The intention is to enhance treatment effectiveness and improve the health results of patients. HIF-2α inhibitors are a unique category of drugs engineered to interrupt the function of HIF-2α, a protein that primarily manages the body's reaction to low levels of oxygen. For example, in December 2023, Merck & Co. Inc., a healthcare company based in the US, secured the U.S. Food and Drug Administration (FDA) approval for an oral HIF-2α inhibitor named WELIREG (belzutifan). This cutting-edge treatment solution is exclusively designed for patients that have previously been treated with PD-1 or PD-L1 inhibitors and VEGF-TKI therapies. This FDA approval is particularly noteworthy, offering a new therapeutic solution for a group with limited treatment alternatives and the potential for improved results and more efficient handling of advanced RCC.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/advanced-renal-cell-carcinoma-treatment-global-market-report
What Are the Top Revenue-Generating Geographies in the Advanced Renal Cell Carcinoma Treatment Market?
North America was the largest region in the advanced renal cell carcinoma treatment market in 2024. The regions covered in the advanced renal cell carcinoma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Advanced Renal Cell Carcinoma Treatment Market?
2. What is the CAGR expected in the Advanced Renal Cell Carcinoma Treatment Market?
3. What Are the Key Innovations Transforming the Advanced Renal Cell Carcinoma Treatment Industry?
4. Which Region Is Leading the Advanced Renal Cell Carcinoma Treatment Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advanced Renal Cell Carcinoma Treatment Market Size Projected To Reach 11.77 Billion By 2034 With A Cagr Of 7.7% here
News-ID: 4069430 • Views: …
More Releases from The Business Research Company
Emerging Trends Influencing The Growth Of The Post Operative Pain Management Mar …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Post Operative Pain Management Market Size Expected to Be by 2034?
The size of the postoperative pain management market has seen considerable expansion lately. It is expected to escalate from $37.03 billion in 2024 to $39.38 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.4%.…
Impact Of Rising Genetic Disorder Prevalence On The Market: An Emerging Driver T …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Adenosine Deaminase-Severe Combined Immunodeficiency Market?
The market size of adenosine deaminase-severe combined immunodeficiency has seen robust growth in the past few years. It is projected to grow from $5.57 billion in 2024 to $5.95 billion in 2025, reflecting a compound annual growth rate (CAGR) of…
Strong Growth Ahead: Synthetic Data Market Size To Grow At Arecord 35% Cagr By 2 …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Big Is the Synthetic Data Market Size Expected to Be by 2034?
The market size for synthetic data has seen substantial growth in recent years. It is projected to increase from $0.51 billion in 2024 to $0.69 billion in 2025, representing a compound annual growth rate (CAGR) of 35.2%. The past growth can…
Pelvic Inflammatory Disease (PID) Treatment Market Forecast 2025-2034: Comprehen …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Pelvic Inflammatory Disease (PID) Treatment Market?
In recent times, the market size for the treatment of pelvic inflammatory disease (PID) has seen significant growth. The market is expected to expand from $4.49 billion in 2024 to $4.75 billion in 2025, indicating a compound annual growth…
More Releases for Treatment
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
Health Tourism Market Global Industry Analysis, By Key Players, Segmentation, Tr …
Huge increase in demand and new phenomenon in the healthcare industry known as health tourism. It is one of the fastest growing industry and economic growth areas globally, as people today demanding for better quality, faster and cheaper alternatives of healthcare offered in their own countries. Health tourism is also known as medical travel or global health care, defined as the act of travelling to foreign countries with purpose of…
Addiction Treatment Market: Tobacco/Nicotine Addiction Treatment Dominates the M …
Transparency Market Research (TMR) has published a new report titled “Addiction Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smoking…
